Cardiovascular Implants Global Market is Projected to Increase Revenues Growth, Business Insights, Future Demand and Forecast 2024-2033 | Medtronic PLC, Abiomed Inc., Livanova PLC, CryoLife Inc., Endologix Inc.

"The new report published by The Business Research Company, titled ""Cardiovascular Implants Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the cardiovascular implants market size has grown strongly in recent years. It will grow from $24.81 billion in 2023 to $26.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $34.59 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp

Rising Prevalence Of Heart Disorders
The rising prevalence of heart disorders is expected to propel the growth of the cardiovascular implants market going forward. Heart disorders refer to various medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The prevalence of heart diseases, such as coronary artery disease and heart failure, drives the demand for cardiovascular implants, including stents and pacemakers, to treat these conditions. These implants support the heart and circulation in patients with heart failure, help the heart beat in a regular rhythm, and keep track of the heart rhythm. For instance, in April 2023, according to the British Heart Foundation, a UK-based cardiovascular research charity, the overall number of deaths in Scotland from all heart and circulatory illnesses was 17,639 in 2021, up from 17,448 in 2020. In addition, the number of deaths from coronary heart disease in the UK in 2021 will be 65,579, up from 64,170 in 2020. Therefore, the rising prevalence of heart disorders is driving the growth of the cardiovascular implants market.

Increasing Focus On Adopting Advanced Technology With Artificial Intelligence (AI) To Maximize Profit
Major companies operating in the cardiovascular implants market are increasing their focus on adopting advanced technology with artificial intelligence (AI) to maximize their profits in the market and enhance patient care and treatment precision. The advancement of cardiac monitoring technology refers to continuously tracking and recording a patient's heart activity to diagnose and manage heart conditions. For instance, in June 2023, BIOTRONIK SE & Co. KG, a Germany-based medical technology company, launched the first global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). BIOMONITOR IV is a cutting-edge ICM that combines BIOTRONIK's SmartECG technology with artificial intelligence to cut false-positive detections by 86% while retaining 98% of real episodes. In addition to the sophisticated artificial intelligence, there are several other advantages for patients and healthcare professionals who use BIOMONITOR IV. Lengthy battery life and wireless connectivity provide smooth data transmission and remote monitoring, decreasing the need for frequent in-person clinic visits.

The cardiovascular implants market covered in this report is segmented -
1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13399&type=discount

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

Contents of the report:
1. Executive Summary
2. Cardiovascular Implants Market Report Structure
3. Cardiovascular Implants Market Trends And Strategies
4. Cardiovascular Implants Market - Macro Economic Scenario
5. Cardiovascular Implants Market Size And Growth
…..
27. Cardiovascular Implants Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.